PINTHUS, Jehonathan. Follicle stimulating hormone (FSH): A potential surrogate marker for androgen deprivation therapy (ADT) oncological and systemic effects. Canadian Urological Association Journal, [S. l.], v. 9, n. 3-4, p. E226–7, 2015. DOI: 10.5489/cuaj.2874. Disponível em: https://cuaj.ca/index.php/journal/article/view/2874. Acesso em: 7 may. 2026.